{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:08:52Z","timestamp":1789016932391,"version":"build-2803163510"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Elderly patients with coexisting coronary artery disease (CAD) and atrial fibrillation (AF) are at significantly increased risk of mortality. Accurate risk stratification is crucial for improving clinical management, yet a dedicated predictive tool for this specific population is lacking. The widely used CHA\n                      <jats:sub>2<\/jats:sub>\n                      DS\n                      <jats:sub>2<\/jats:sub>\n                      -VASc score demonstrates limited performance in predicting all-cause mortality in this complex comorbid group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A cohort of elderly inpatients (\u226565 years) diagnosed with CAD and AF were retrospectively enrolled from the Department of Cardiology at the Chinese PLA General Hospital between January 2010 and December 2017. Baseline clinical data during hospitalization were collected, and all patients were followed up for all-cause mortality. Patients were randomly divided into a training set (70%) and a validation set (30%). Variable selection was performed using LASSO-Cox regression. Predictive models were established through a Cox proportional hazards model (via LASSO-Cox) to predict all-cause mortality risk. To assess model robustness and address potential overfitting, we performed 10-fold cross-validation and bootstrap resampling (500 replicates) with optimism-corrected C-statistics. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), calibration curves, and decision curve analysis (DCA), and compared against the CHA\n                      <jats:sub>2<\/jats:sub>\n                      DS\n                      <jats:sub>2<\/jats:sub>\n                      -VASc score.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 1678 elderly patients with CAD and AF were randomly divided into a training set (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091174) and a validation set (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009504). Through LASSO-Cox regression, 17 variables were identified as predictors associated with all-cause mortality. Two distinct models were developed: LASSO-Cox Model A included factors such as age, left ventricular ejection fraction, blood glucose, plasma fibrinogen, D-dimer, prothrombin time, NT-proBNP, hemoglobin, and hematocrit; LASSO-Cox Model B incorporated all variables from Model A plus acute myocardial infarction, history of myocardial infarction, renal insufficiency, heart failure, diabetes, stroke, chronic obstructive pulmonary disease, and malignant tumor.\n                    <\/jats:p>\n                    <jats:p>\n                      The analysis of Cox proportional hazards regression models showed that in the training sets, the Area Under Curves (AUC) of model A, model B and CHA\n                      <jats:sub>2<\/jats:sub>\n                      DS\n                      <jats:sub>2<\/jats:sub>\n                      -VASc scores for predicting 1-year all-cause death were 0.83, 0.85 and 0.66, respectively; the AUC for 5-year all-cause death were 0.74, 0.76 and 0.62, respectively. In the validation sets, the AUC of model A, model B and the CHA\n                      <jats:sub>2<\/jats:sub>\n                      DS\n                      <jats:sub>2<\/jats:sub>\n                      -VASc score for predicting 1-year all-cause mortality were 0.79, 0.78 and 0.57, respectively; the AUC for 5-year all-cause death were 0.74, 0.75 and 0.57, respectively. The 10-fold cross-validation yielded a mean AUC of 0.83 (SD: 0.04) for 1-year mortality, and bootstrap resampling produced an optimism-corrected C-statistic of 0.679 (95% CI: 0.651\u20130.708), confirming that the model maintains clinically meaningful discriminative ability after accounting for optimism. Model B demonstrated better calibration and provided greater net clinical benefit in DCA.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The LASSO-Cox machine learning model demonstrates superior predictive performance for all cause mortality relative to the traditional CHA\n                      <jats:sub>2<\/jats:sub>\n                      DS\n                      <jats:sub>2<\/jats:sub>\n                      -VASc score in elderly patients with CAD and AF.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1860173","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:29:42Z","timestamp":1789014582000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Mortality prediction in the elderly patients with coronary artery disease and atrial fibrillation: a retrospective machine learning approach"],"prefix":"10.3389","volume":"13","author":[{"given":"Yuyan","family":"Wang","sequence":"first","affiliation":[{"name":"Institute of Geriatrics, Beijing Key Laboratory of Geriatric Multimorbidity Research, National Clinical Research Center for Geriatric Diseases, the Second Medical Center, Chinese PLA General Hospital","place":["Beijing, China"]},{"name":"Medical School of Chinese PLA and Chinese PLA General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangxun","family":"Wu","sequence":"additional","affiliation":[{"name":"Institute of Geriatrics, Beijing Key Laboratory of Geriatric Multimorbidity Research, National Clinical Research Center for Geriatric Diseases, the Second Medical Center, Chinese PLA General Hospital","place":["Beijing, China"]},{"name":"Medical School of Chinese PLA and Chinese PLA General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Zou","sequence":"additional","affiliation":[{"name":"Institute of Geriatrics, Beijing Key Laboratory of Geriatric Multimorbidity Research, National Clinical Research Center for Geriatric Diseases, the Second Medical Center, Chinese PLA General Hospital","place":["Beijing, China"]},{"name":"Medical School of Chinese PLA and Chinese PLA General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Mao","sequence":"additional","affiliation":[{"name":"Institute of Geriatrics, Beijing Key Laboratory of Geriatric Multimorbidity Research, National Clinical Research Center for Geriatric Diseases, the Second Medical Center, Chinese PLA General Hospital","place":["Beijing, China"]},{"name":"Medical School of Chinese PLA and Chinese PLA General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhu","family":"Yao","sequence":"additional","affiliation":[{"name":"Institute of Geriatrics, Beijing Key Laboratory of Geriatric Multimorbidity Research, National Clinical Research Center for Geriatric Diseases, the Second Medical Center, Chinese PLA General Hospital","place":["Beijing, China"]},{"name":"Medical School of Chinese PLA and Chinese PLA General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Geriatrics, Beijing Key Laboratory of Geriatric Multimorbidity Research, National Clinical Research Center for Geriatric Diseases, the Second Medical Center, Chinese PLA General Hospital","place":["Beijing, China"]},{"name":"Medical School of Chinese PLA and Chinese PLA General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Institute of Geriatrics, Beijing Key Laboratory of Geriatric Multimorbidity Research, National Clinical Research Center for Geriatric Diseases, the Second Medical Center, Chinese PLA General Hospital","place":["Beijing, China"]},{"name":"Medical School of Chinese PLA and Chinese PLA General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Lv","sequence":"additional","affiliation":[{"name":"Institute of Geriatrics, Beijing Key Laboratory of Geriatric Multimorbidity Research, National Clinical Research Center for Geriatric Diseases, the Second Medical Center, Chinese PLA General Hospital","place":["Beijing, China"]},{"name":"Medical School of Chinese PLA and Chinese PLA General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Fan","sequence":"additional","affiliation":[{"name":"Institute of Geriatrics, Beijing Key Laboratory of Geriatric Multimorbidity Research, National Clinical Research Center for Geriatric Diseases, the Second Medical Center, Chinese PLA General Hospital","place":["Beijing, China"]},{"name":"Medical School of Chinese PLA and Chinese PLA General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Yin","sequence":"additional","affiliation":[{"name":"Institute of Geriatrics, Beijing Key Laboratory of Geriatric Multimorbidity Research, National Clinical Research Center for Geriatric Diseases, the Second Medical Center, Chinese PLA General Hospital","place":["Beijing, China"]},{"name":"Medical School of Chinese PLA and Chinese PLA General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1055\/s-0042-1751234","article-title":"Epidemiology, pathophysiology, and management of coronary artery disease in the elderly","volume":"31","author":"Fadah","year":"2022","journal-title":"Int J Angiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccep.2020.10.010","article-title":"Epidemiology of atrial fibrillation: geographic\/ecological risk factors, age, sex, genetics","volume":"13","author":"Zhang","year":"2021","journal-title":"Card Electrophysiol Clin"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/S0140-6736(25)00449-0","article-title":"Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial","volume":"405","author":"Choi","year":"2025","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.jacc.2024.12.030","article-title":"Anticoagulation and antiplatelet therapy for atrial fibrillation and stable coronary disease: meta-analysis of randomized trials","volume":"85","author":"Rashedi","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.31083\/j.rcm2202049","article-title":"Prognostic implications of atrial fibrillation in patients with stable coronary artery disease: a systematic review and meta-analysis of adjusted observational studies","volume":"22","author":"Saglietto","year":"2021","journal-title":"Rev Cardiovasc Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"4553","DOI":"10.1093\/eurheartj\/ehab575","article-title":"Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation: a nationwide study","volume":"42","author":"Petersen","year":"2021","journal-title":"Eur Heart J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"805234","DOI":"10.3389\/fcvm.2021.805234","article-title":"Assessment of the CHA2DS2-VASc score for the prediction of death in elderly patients with coronary artery disease and atrial fibrillation","volume":"8","author":"Wu","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1001\/jama.2025.14679","article-title":"Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation: the ALONE-AF randomized clinical trial","volume":"334","author":"Kim","year":"2025","journal-title":"JAMA"},{"key":"B10","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/clc.23786","article-title":"CHA\u2082DS\u2082-VASc and PESI scores are associated with right ventricular dysfunction on computed tomography pulmonary angiography in patients with acute pulmonary thromboembolism","volume":"45","author":"Alirezaei","year":"2022","journal-title":"Clin Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/clc.24037","article-title":"N-terminal pro-B-type natriuretic peptide improves the predictive value of CHA\u2082DS\u2082-VASc risk score for long-term cardiovascular events in acute coronary syndrome patients with atrial fibrillation","volume":"46","author":"Mu","year":"2023","journal-title":"Clin Cardiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jjcc.2020.08.013","article-title":"Prediction of acute-coronary-syndrome using newly-defined R2-CHA2DS2-VASc score among patients with chest pain","volume":"77","author":"Topaz","year":"2021","journal-title":"J Cardiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e21321","DOI":"10.1097\/MD.0000000000021321","article-title":"Prognostic value of CHADS2 and CHA2DS2-VASc scores for post-discharge outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention","volume":"99","author":"Ma","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/eurheartj\/ehac515","article-title":"Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 update by the ESC Working Group on Thrombosis","volume":"44","author":"Andreotti","year":"2023","journal-title":"Eur Heart J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"730453","DOI":"10.3389\/fcvm.2021.730453","article-title":"Predicting all-cause mortality risk in atrial fibrillation patients: a novel LASSO-cox model generated from a prospective dataset","volume":"8","author":"Chen","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s13054-024-05138-0","article-title":"Interpretable machine learning model for new-onset atrial fibrillation prediction in critically ill patients: a multi-center study","volume":"28","author":"Guan","year":"2024","journal-title":"Crit Care"},{"key":"B17","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1161\/CIRCULATIONAHA.122.060402","article-title":"Metabolomic profiling of the effects of dapagliflozin in heart failure with reduced ejection fraction: DEFINE-HF","volume":"146","author":"Selvaraj","year":"2022","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41586-025-09350-y","article-title":"Population-specific polygenic risk scores for people of Han Chinese ancestry","volume":"648","author":"Chen","year":"2025","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ajhg.2018.11.002","article-title":"Polygenic risk scores for prediction of breast cancer and breast cancer subtypes","volume":"104","author":"Mavaddat","year":"2019","journal-title":"Am J Hum Genet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1080\/10618600.2014.938812","article-title":"Learning interactions via hierarchical group-lasso regularization","volume":"24","author":"Lim","year":"2015","journal-title":"J Comput Graph Stat"},{"key":"B22","article-title":"A regularization-based adaptive test for high-dimensional generalized linear models","volume":"21","author":"Wu","year":"2020","journal-title":"J Mach Learn Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/europace\/euy174","article-title":"2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and\/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA)","volume":"21","author":"Lip","year":"2019","journal-title":"Europace"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/S0140-6736(15)00453-5","article-title":"ICD-10: there\u2019s a code for that","volume":"386","year":"2015","journal-title":"Lancet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"103187","DOI":"10.1016\/j.artmed.2025.103187","article-title":"Deep learning for automatic ICD coding: review, opportunities and challenges","volume":"168","author":"Li","year":"2025","journal-title":"Artif Intell Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/ehf2.15042","article-title":"N-terminal pro-brain natriuretic peptide and cardiorenal outcome in patients with anaemia in chronic kidney disease","volume":"12","author":"Nishi","year":"2025","journal-title":"ESC Heart Fail"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.jacc.2018.11.054","article-title":"The interleukin-1 axis and risk of death in patients with acutely decompensated heart failure","volume":"73","author":"Pascual-Figal","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/MEJ.0000000000001053","article-title":"Acute heart failure in elderly patients admitted to the emergency department with acute dyspnea: a multimarker approach diagnostic study","volume":"30","author":"Taheri","year":"2023","journal-title":"Eur J Emerg Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1093\/clinchem\/hvac126","article-title":"Assays specific for BNP1-32 and NT-proBNP exhibit a similar performance to two widely used assays in the diagnosis of heart failure","volume":"68","author":"Lewis","year":"2022","journal-title":"Clin Chem"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.jacc.2018.01.021","article-title":"N-terminal pro-B-type natriuretic peptide in the emergency department: the ICON-RELOADED study","volume":"71","author":"Januzzi","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1471-2261-14-67","article-title":"Plasma NT pro-BNP, hs-CRP and big-ET levels at admission as prognostic markers of survival in hospitalized patients with dilated cardiomyopathy: a single-center cohort study","volume":"14","author":"Li","year":"2014","journal-title":"BMC Cardiovasc Disord"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1093\/eurheartj\/ehs469","article-title":"All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995\u20132008: a Swedish nationwide long-term case-control study","volume":"34","author":"Andersson","year":"2013","journal-title":"Eur Heart J"},{"key":"B34","doi-asserted-by":"publisher","first-page":"258","DOI":"10.5551\/jat.ED064","article-title":"Risk factor of cardiovascular disease among older individuals","volume":"24","author":"Yatsuya","year":"2017","journal-title":"J Atheroscler Thromb"},{"key":"B35","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12933-022-01546-0","article-title":"Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis","volume":"21","author":"Liu","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12967-020-02319-7","article-title":"A LASSO-derived risk model for long-term mortality in Chinese patients with acute coronary syndrome","volume":"18","author":"Li","year":"2020","journal-title":"J Transl Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1022658","DOI":"10.3389\/fcvm.2022.1022658","article-title":"A prediction model for major adverse cardiovascular events in patients with heart failure based on high-throughput echocardiographic data","volume":"9","author":"Sun","year":"2022","journal-title":"Front Cardiovasc Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1860173\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:29:45Z","timestamp":1789014585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1860173\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":37,"alternative-id":["10.3389\/fmed.2026.1860173"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1860173","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"article-number":"1860173"}}